Latest Americord Stories
Funds Will Support Research Into Safety and Efficacy of Genetically Unmatched Cord Blood Stem Cell Transplantations Using a Myeloablative Preparative Regimen. NEW YORK, Dec.
Americord launches revolutionary process, Cord Blood 2.0™ to preserve up to twice as many stem cells in umbilical cord blood. New York, NY (PRWEB) October
Research explores the benefits of using autologous cord blood stem cells for children with Cerebral Palsy NEW YORK, Sept.
Hoskins Joins Leading Doctors to Help Guide Americord's Innovations in Cord Blood Banking NEW YORK, July 15, 2014 /PRNewswire/ --
Americord's Significant Investment in Brooklyn Will Create New Jobs in New York NEW YORK, June 11, 2014 /PRNewswire/ -- Americord
Americord Yields 60% More CD34+ Stem Cells, 54% More Cord Blood, and 34% Higher TNC Than Competitors NEW YORK, May 27, 2014 /PRNewswire/ -- Americord announced today that its cord
Abstract Presented at ASPHO Conference by Americord's Medical Director Dr.
Funds Will Support Research Into Safety and Efficacy of NEUROSTEM-AD® NEW YORK, May 5, 2014 /PRNewswire/ -- Americord
Americord CEO Interviewed For Article Exploring Good And Bad Practices In The Industry NEW YORK, April 28, 2014 /PRNewswire/ -- Americord Registry client Whitney Ferrarese
Americord Raises Standards of Customer Service in Cord Blood Industry NEW YORK, April 14, 2014 /PRNewswire/ --